Registro:

Referencias:

• McFarland, H.F., Martin, R., Multiple sclerosis: A complicated picture of autoimmunity (2007) Nat. Immunol., 8, pp. 913-919
• Ascherio, A., Munger, K.L., Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors (2007) Annals of Neurology, 61 (6), pp. 504-513. , DOI 10.1002/ana.21141
• Pugliatti, M., Harbo, H.F., Holmøy, T., Kampman, M.T., Myhr, K.M., Riise, T., Wolfson, C., Environmental risk factors in multiple sclerosis (2008) Acta Neurol. Scand. Suppl., 188, pp. 34-40
• Oksenberg, J.R., Baranzini, S.E., Sawcer, S., Hauser, S.L., The genetics of multiple sclerosis: SNPs to pathways to pathogenesis (2008) Nat. Rev. Genet., 9, pp. 516-526
• Ebers, G.C., Bulman, D.E., Sadovnick, A.D., Paty, D.W., Warren, S., Hader, W., Murray, T.J., Grey, T., A population-based study of multiple sclerosis in twins (1986) N. Engl. J. Med., 315, pp. 1638-1642
• Elian, M., Nightingale, S., Dean, G., Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies (1990) J. Neurol. Neurosurg. Psychiatry, 53, pp. 906-911
• Kahana, E., Zilber, N., Abramson, J.H., Biton, V., Leibowitz, Y., Abramsky, O., Multiple sclerosis: Genetic versus environmental aetiology: Epidemiology in Israel updated (1994) J. Neurol., 241, pp. 341-346
• Van Der Mei, I.A., Ponsonby, A.L., Dwyer, T., Blizzard, L., Simmons, R., Taylor, B.V., Butzkueven, H., Kilpatrick, T., Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case-control study (2003) BMJ, 327, p. 316
• Munger, K.L., Zhang, S.M., O'Reilly, E., Hernán, M.A., Olek, M.J., Willett, W.C., Ascherio, A., Vitamin D intake and incidence of multiple sclerosis (2004) Neurology, 62, pp. 60-65
• Acheson, E.D., Bachrach, C.A., Wright, F.M., Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables (1960) Acta Psychiatr. Scand. Suppl., 35, pp. 132-147
• Goldberg, P., Multiple Sclerosis: Vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part I: Sunlight, dietary factors and epidemiology (1974) Int. J. Environ. Stud., 6, pp. 19-27
• Hayes, C.E., Cantorna, M.T., DeLuca, H.F., Vitamin D and multiple sclerosis (1997) Proc. Soc. Exp. Biol. Med., 216, pp. 21-27
• Tremlett, H., Van Der Mei, I.A., Pittas, F., Blizzard, L., Paley, G., Mesaros, D., Woodbaker, R., Ponsonby, A.L., Monthly ambient sunlight, infections and relapse rates in multiple sclerosis (2008) Neuroepidemiology, 31, pp. 271-279
• Soilu-Hänninen, M., Laaksonen, M., Laitinen, I., Erälinna, J.P., Lilius, E.M., Mononen, I., A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis (2008) J. Neurol. Neurosurg. Psychiatry, 79, pp. 152-157
• Ascherio, A., Munger, K.L., Simon, K.C., Vitamin D and multiple sclerosis (2010) Lancet Neurol., 9, pp. 599-612
• Munger, K.L., Levin, L.I., Hollis, B.W., Howard, N.S., Ascherio, A., Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis (2006) JAMA, 296, pp. 2832-2838
• Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 (2009) Nat. Genet., 41, pp. 824-828. , Australia and New Zealand Multiple Sclerosis Genetics Consortium ANZgene
• Lemire, J.M., Archer, D.C., 1, 25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis (1991) J. Clin. Invest., 87, pp. 1103-1107
• Cantorna, M.T., Hayes, C.E., DeLuca, H.F., 1, 25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 7861-7864
• Van Amerongen, B.M., Dijkstra, C.D., Lips, P., Polman, C.H., Multiple sclerosis and vitamin D: An update (2004) Eur. J. Clin. Nutr., 58, pp. 1095-1109
• Spach, K.M., Hayes, C.E., Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice (2005) J. Immunol., 175, pp. 4119-4126
• Nashold, F.E., Spach, K.M., Spanier, J.A., Hayes, C.E., Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression (2009) J. Immunol., 183, pp. 3672-3681
• Correale, J., Ysrraelit, M.C., Gaitán, M.I., Immunomodulatory effects of Vitamin D in multiple sclerosis (2009) Brain, 132, pp. 1146-1160
• Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebers, G.C., Johnson, K.P., Tourtellotte, W.W., New diagnostic criteria for multiple sclerosis: Guidelines for research protocols (1983) Ann. Neurol., 13, pp. 227-231
• McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., McFarland, H.F., Reingold, S.C., Ann (2001) Neurol., 50, pp. 121-127
• Barany, G., Merrifield, R.B., Solid-phase peptide synthesis (1980) The Peptides: Analysis, Synthesis and Biology, pp. 1-284. , E. Gross, and J. Meinhofer, eds. Academic Press, New York
• Correale, J., McMillan, M., McCarthy, K., Le, T., Weiner, L.P., Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients (1995) Neurology, 45, pp. 1370-1378
• Berthois, Y., Katzenellenbogen, J.A., Katzenellenbogen, B.S., Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture (1986) Proc. Natl. Acad. Sci. USA, 83, pp. 2496-2500
• Esteban, C., Geuskens, M., Ena, J.M., Mishal, Z., Macho, A., Torres, J.M., Uriel, J., Receptor-mediated uptake and processing of vitamin D-binding protein in human B-lymphoid cells (1992) J. Biol. Chem., 267, pp. 10177-10183
• Chun, R.F., Lauridsen, A.L., Suon, L., Zella, L.A., Wesley Pike, J., Modin, R.L., Martineau, A.R., Hewison, M., Vitamin D-binding protein directs monocyte responses to 25-hydroxy-and 1, 25-dihydroxyvitamin D (2010) J. Clin. Endocrinol. Metab., 95, pp. 3368-3376
• Veldman, C.M., Cantorna, M.T., DeLuca, H.F., Expression of 1, 25-dihydroxyvitamin D (3) receptor in the immune system (2000) Arch. Biochem. Biophys., 374, pp. 334-338
• Norman, A.W., Receptors for 1alpha, 25 (OH) 2D3: Past, present, and future (1998) J. Bone Miner. Res., 13, pp. 1360-1369
• Hewison, M., Burke, F., Evans, K.N., Lammas, D.A., Sansom, D.M., Liu, P., Modlin, R.L., Adams, J.S., Extra-renal 25-hydroxyvitamin D3-1alphahydroxylase in human health and disease (2007) J. Steroid Biochem. Mol. Biol., 103, pp. 316-321
• Omdahl, J.L., Morris, H.A., May, B.K., Hydroxylase enzymes of the vitamin D pathway: Expression, function, and regulation (2002) Annu. Rev. Nutr., 22, pp. 139-166
• Yang, F., Brune, J.L., Naylor, S.L., Cupples, R.L., Naberhaus, K.H., Bowman, B.H., Human group-specific component (Gc) is a member of the albumin family (1985) Proc. Natl. Acad. Sci. USA, 82, pp. 7994-7998
• McLeod, J.F., Kowalski, M.A., Haddad, J.G., Characterization of a monoclonal antibody to human serum vitamin D binding protein (Gc globulin): Recognition of an epitope hidden in membranes of circulating monocytes (1986) Endocrinology, 119, pp. 77-83
• Kew, R.R., Sibug, M.A., Liuzzo, J.P., Webster, R.O., Localization and quantitation of the vitamin D binding protein (Gc-globulin) in human neutrophils (1993) Blood, 82, pp. 274-283
• Adams, J.S., Liu, P.T., Chun, R., Modlin, R.L., Hewison, M., Vitamin D in defense of the human immune response (2007) Ann. N. Y. Acad. Sci., 1117, pp. 94-105
• Bischoff-Ferrari, H.A., Giovannucci, E., Willett, W.C., Dietrich, T., Dawson-Hughes, B., Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes (2006) Am. J. Clin. Nutr., 84, pp. 18-28
• (2006) Am. J. Clin. Nutr., 84, p. 1253. , Published errata appear in
• (2007) Am. J. Clin. Nutr., 86, p. 809
• Vieth, R., Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults (2004) J. Steroid Biochem. Mol. Biol., 89-90, pp. 575-579
• Whitacre, C.C., Sex differences in autoimmune disease (2001) Nat. Immunol., 2, pp. 777-780
• Weinstein, Y., Ran, S., Segal, S., Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse (1984) J. Immunol., 132, pp. 656-661
• Amadori, A., Zamarchi, R., De Silvestro, G., Forza, G., Cavatton, G., Danieli, G.A., Clementi, M., Chieco-Bianchi, L., Genetic control of the CD4/CD8 T-cell ratio in humans (1995) Nat. Med., 1, pp. 1279-1283
• Smith, M.E., Eller, N.L., Gender influences EAE both before and after sexual maturation (1996) FASEB J., 10, pp. A1353
• Jansson, L., Olsson, T., Holmdahl, R., Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice (1994) J. Neuroimmunol., 53, pp. 203-207
• Toivanen, P., Siikala, H., Laiho, P., Paavilainen, T., Suppression of adjuvant arthritis by estrone in adrenalectomized and ovariectomized rats (1967) Experientia, 23, pp. 560-561
• Larsson, P., Holmdahl, R., Oestrogen-induced suppression of collagen arthritis. II. Treatment of rats suppresses development of arthritis but does not affect the anti-type II collagen humoral response (1987) Scand. J. Immunol., 26, pp. 579-583
• Confavreux, C., Hutchinson, M., Hours, M.M., Cortinovis-Tourniaire, P., Moreau, T., Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group (1998) N. Engl. J. Med., 339, pp. 285-291
• Whitacre, C.C., Reingold, S.C., O'Looney, P.A., A gender gap in autoimmunity (1999) Science, 283, pp. 1277-1278
• Smith, R., Studd, J.W., A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle (1992) J. R. Soc. Med., 85, pp. 612-613
• Sicotte, N.L., Liva, S.M., Klutch, R., Pfeiffer, P., Bouvier, S., Odesa, S., Wu, T.C., Voskuhl, R.R., Treatment of multiple sclerosis with the pregnancy hormone estriol (2002) Ann. Neurol., 52, pp. 421-428
• Gilmore, W., Weiner, L.P., Correale, J., Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects (1997) J. Immunol., 158, pp. 446-451
• Offner, H., Polanczyk, M., A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis (2006) Ann. N. Y. Acad. Sci., 1089, pp. 343-372
• Ito, A., Bebo, B.F., Matejuk Jr., A., Zamora, A., Silverman, M., Fyfe-Johnson, A., Offner, H., Estrogen treatment down-regulates TNF-a production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice (2001) J. Immunol., 167, pp. 542-552
• Matejuk, A., Adlard, K., Zamora, A., Silverman, M., Vandenbark, A.A., Offner, H., 17 b-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis (2001) J. Neurosci. Res., 65, pp. 529-542
• Liu, H.Y., Buenafe, A., Matejuk, A., Ito, A., Zamora, A., Dwyer, J., Vandenbark, A.A., Offner, H., Estrogen inhibition of EAE involves effects on dendritic cell function (2002) J. Neurosci. Res., 70, pp. 238-248
• Polanczyk, M.J., Carson, B.D., Subramanian, S., Afentoulis, M., Vandenbark, A.A., Ziegler, S.F., Offner, H., Cutting edge: Estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment (2004) J. Immunol., 173, pp. 2227-2230
• Matejuk, A., Dwyer, J., Hopke, C., Vandenbark, A.A., Offner, H., Opposing roles for TGF-beta1 and TGF-beta3 isoforms in experimental autoimmune encephalomyelitis (2004) Cytokine, 25, pp. 45-51
• Toran-Allerand, C.D., Singh, M., Sétáló Jr., G., Novel mechanisms of estrogen action in the brain: New players in an old story (1999) Front. Neuroendocrinol, 20, pp. 97-121
• Langub, M.C., Herman, J.P., Malluche, H.H., Koszewski, N.J., Evidence of functional vitamin D receptors in rat hippocampus (2001) Neuroscience, 104, pp. 49-56
• Prüfer, K., Jirikowski, G.F., 1.25-Dihydroxyvitamin D3 receptor is partly colocalized with oxytocin immunoreactivity in neurons of the male rat hypothalamus (1997) Cell. Mol. Biol. (Noisy-le-grand), 43, pp. 543-548
• Baas, D., Prüfer, K., Ittel, M.E., Kuchler-Bopp, S., Labourdette, G., Sarliève, L.L., Brachet, P., Rat oligodendrocytes express the vitamin D (3) receptor and respond to 1, 25-dihydroxyvitamin D (3) (2000) Glia, 31, pp. 59-68
• Neveu, I., Naveilhan, P., Jehan, F., Baudet, C., Wion, D., De Luca, H.F., Brachet, P., 1, 25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells (1994) Brain Res. Mol. Brain Res., 24, pp. 70-76
• Wion, D., MacGrogan, D., Neveu, I., Jehan, F., Houlgatte, R., Brachet, P., 1, 25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis (1991) J. Neurosci. Res., 28, pp. 110-114
• Lösel, R., Wehling, M., Nongenomic actions of steroid hormones (2003) Nat. Rev. Mol. Cell. Biol., 4, pp. 46-56
• Brewer, L.D., Thibault, V., Chen, K.C., Langub, M.C., Landfield, P.W., Porter, N.M., Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons (2001) J. Neurosci., 21, pp. 98-108
• Gray, T.K., McAdoo, T., Hatley, L., Lester, G.E., Thierry, M., Fluctuation of serum concentration of 1, 25-dihydroxyvitamin D3 during the menstrual cycle (1982) Am. J. Obstet. Gynecol., 144, pp. 880-884
• Elenkov, I.J., Wilder, R.L., Bakalov, V.K., Link, A.A., Dimitrov, M.A., Fisher, S., Kanik, K.S., Chrousos, G.P., IL-12, TNF-a and hormonal changes during late pregnancy and early postpartum: Implications for autoimmune disease activity during these times (2001) J. Clin. Endocrinol. Metab., 86, pp. 4933-4938
• Aarskog, D., Aksnes, L., Markestad, T., Rødland, O., Effect of estrogen on vitamin D metabolism in tall girls (1983) J. Clin. Endocrinol. Metab., 57, pp. 1155-1158
• Duncan, W.E., Glass, A.R., Wray, H.L., Estrogen regulation of the nuclear 1, 25-dihydroxyvitamin D3 receptor in rat liver and kidney (1991) Endocrinology, 129, pp. 2318-2324
• Elloso, M.M., Phiel, K., Henderson, R.A., Harris, H.A., Adelman, S.J., Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands (2005) J. Endocrinol., 185, pp. 243-252
• Harris, H.A., Katzenellenbogen, J.A., Katzenellenbogen, B.S., Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand (2002) Endocrinology, 143, pp. 4172-4177
• Tiwari-Woodruff, S., Morales, L.B., Lee, R., Voskhul, R.R., Differential neuroprotective and anti-inflammatory effects of estrogen receptor (ER) a and ERb ligand treatment (2007) Proc. Natl. Acad. Sci. USA, 104, pp. 14813-14818
• Polanczyk, M.J., Jones, R.E., Subramanian, S., Afentoulis, M., Rich, C., Zakroczymski, M., Cooke, P., Offner, H., T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis (2004) Am. J. Pathol., 165, pp. 2069-2077
• Cooke, N.E., Walgate, J., Haddad Jr., J.G., Human serum binding protein for vitamin D and its metabolites. II. Specific, high affinity association with a protein in nucleated tissue (1979) Journal of Biological Chemistry, 254 (13), pp. 5965-5971
• Adams, J.S., Chen, H., Chun, R., Ren, S., Wu, S., Gacad, M., Nguyen, L., Hewison, M., Substrate and enzyme trafficking as a means of regulating 1, 25-dihydroxyvitamin D synthesis and action: The human innate immune response (2007) J. Bone Miner. Res., 22 (2 SUPPL.), pp. V20-V24
• Rowling, M.J., Kemmis, C.M., Taffany, D.A., Welsh, J.E., Megalinmediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells (2006) J. Nutr., 136, pp. 2754-2759
• Wu, S., Ren, S., Chen, H., Chun, R.F., Gacad, M.A., Adams, J.S., Intracellular vitamin D binding proteins: Novel facilitators of vitamin D-directed transactivation (2000) Mol. Endocrinol., 14, pp. 1387-1397
• Hammes, A., Andreassen, T.K., Spoelgen, R., Raila, J., Hubner, N., Schulz, H., Metzger, J., Willnow, T.E., Role of endocytosis in cellular uptake of sex steroids (2005) Cell., 122, pp. 751-762
• Marino, M., Zheng, G., Chiovato, L., Pinchera, A., Brown, D., Andrews, D., McCluskey, R.T., Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novel function in the control of thyroid hormone release (2000) J. Biol. Chem., 275, pp. 7125-7137

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------